Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

072020.KQ

BUYREMOVE

Choong Ang Vaccine Laboratory Co., Ltd. · Healthcare · South Korea · $57M · Avg Vol: $140K/d

77
StockRank
Q
59
V
63
M
44
P/E (TTM)
14.3x
ROE
3.8%
D/E
0.1x
Dividend %
2.2%
AI CONVICTION THESIS

Choong Ang Vaccine Laboratory is a niche animal vaccine manufacturer. It lacks the scale, pricing power, and global distribution network required to meet our quality compounder threshold.

COMPANY DESCRIPTION

Choong Ang Vaccine Laboratory Co., Ltd. develops, manufactures, and distributes veterinary vaccines and biopharmaceuticals for livestock, poultry, and companion animals. The company's competitive advantage lies in its extensive portfolio of proprietary vaccines tailored to regional animal diseases and its strong domestic distribution network. It is a leading animal health player in South Korea, increasingly targeting export markets in Southeast Asia.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue25.6M27.3M29.7M32.0M7.7%
EPS0.270.400.460.4316.5%
Shares10.0M9.7M9.7M9.4M-6.1%
Debt8.2M7.2M5.8M4.6M-17.4%
Equity62.1M65.0M67.6M68.6M3.4%
Op CF4.6M8.3M8.7M5.1M3.6%
Inv CF-6.0M-2.2M-6.5M-2.9M
Fin CF-1.0M-1.8M-3.1M-4.2M
Loading...
PRICE (1Y)-9.3%
5.976.126.286.446.60May 14Jun 8Jun 26
SMA 50SMA 200
Close
$5.98
RSI (14)
47.6
52W High
$6.74
From 52W High
0.9%

SCORE BREAKDOWN

Quality
59
ROIC
6.1%60.6
ROE
3.8%53.1
GP/Assets
14.9%35.1
Op. Margin
18.5%80.5
FCF/Assets
-0.4%49.3
Piotroski
782.3
Int. Cover
31.5x73.7
D/E Ratio
0.12x63.8
Current Ratio
3.11x55.0
Value
63
P/E (TTM)
14.3x75.7
EV/EBITDA
8.2x77.0
P/FCF
N/A
P/B
0.8x88.2
P/S
2.2x64.5
Div Yield
2.2%53.0
Momentum
44
52W High %
89%86.3
RS 6M
-109%8.0
SMA 50/200
1.01x66.1
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
N/A
Q Growth
-18%26.8

FUNDAMENTALS

Market Cap
$57M
P/E (Forward)
Gross Margin
47.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 072020.KQ are excluded.

TickerCompanyMkt CapStockRankSignal
072020.KQChoong Ang Vaccine Laboratory Co., Ltd.(you)$57M77BUY
131030.KQDHP Korea Co., Ltd.$62M72BUY
002620.KSJeil Pharma Holdings Inc$68M72BUY
330350.KQWITHUS PHARMACEUTICAL Co.,LTD.$73M66BUY
054670.KQDaehan Nupharm Co.,Ltd.$51M62HOLD
008490.KSSuheung Co., Ltd.$132M79BUY
106190.KQHigh Tech Pharm Co., Ltd.$100M66BUY
023910.KQDaihan Pharmaceutical Co.,Ltd.$96M90STRONG BUY
001540.KQAhn-Gook Pharmaceutical Co., Ltd.$74M99STRONG BUY
293480.KSHana Pharm Co., Ltd.$103M61HOLD

Peer medians: ROE 0.1% · P/E 16.8x · Gross margin 43.8%

Choong Ang Vaccine Laboratory Co., Ltd. (072020.KQ) — Stock Score Summary

Choong Ang Vaccine Laboratory Co., Ltd. (072020.KQ) has a MoatMap StockRank of 77/100 based on Quality (59/100), Value (63/100), and Momentum (44/100) factor scores. The current signal is BUY. Choong Ang Vaccine Laboratory is a niche animal vaccine manufacturer. It lacks the scale, pricing power, and global distribution network required to meet our quality compounder threshold.

Choong Ang Vaccine Laboratory Co., Ltd. develops, manufactures, and distributes veterinary vaccines and biopharmaceuticals for livestock, poultry, and companion animals. The company's competitive advantage lies in its extensive portfolio of proprietary vaccines tailored to regional animal diseases and its strong domestic distribution network. It is a leading animal health player in South Korea, increasingly targeting export markets in Southeast Asia.

Key Financial Metrics

Price$5.98
Market Cap$57M
P/E (TTM)14.25
Price/Book0.83
Return on Equity3.8%
Return on Invested Capital6.1%
Debt/Equity11.60
Gross Margin47.6%
Operating Margin18.5%
Revenue Growth-1.1%
Dividend Yield2.2%
Free Cash Flow$-331K

Choong Ang Vaccine Laboratory Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Choong Ang Vaccine Laboratory Co., Ltd.’s (072020.KQ) StockRank?
MoatMap’s StockRank for Choong Ang Vaccine Laboratory Co., Ltd. (072020.KQ) is 77/100, with a Buy signal. It is a composite of Quality (59), Value (63), and Momentum (44) factor ranks across MoatMap’s 20,000+ stock universe.
Does Choong Ang Vaccine Laboratory Co., Ltd. have an economic moat?
Choong Ang Vaccine Laboratory Co., Ltd. (072020.KQ) has a Quality factor score of 59/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Choong Ang Vaccine Laboratory Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Choong Ang Vaccine Laboratory Co., Ltd. (072020.KQ) is Buy, based on a StockRank of 77/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Choong Ang Vaccine Laboratory Co., Ltd. in?
Choong Ang Vaccine Laboratory Co., Ltd. (072020.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).